These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34287983)

  • 41. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Seronegative myasthenia gravis].
    Catar O; Aubé-Nathier AC; Nadaj-Pakleza A
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():34-38. PubMed ID: 29139384
    [No Abstract]   [Full Text] [Related]  

  • 43. High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
    Uzawa A; Akamine H; Kojima Y; Ozawa Y; Yasuda M; Onishi Y; Sawai S; Kawasaki K; Asano H; Ohyama S; Matsushita K; Mori M; Kuwabara S
    J Neuroimmunol; 2021 Sep; 358():577634. PubMed ID: 34174586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
    Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
    J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquired myasthenia gravis in a poodle.
    Richardson D
    Can Vet J; 2011 Feb; 52(2):169-72. PubMed ID: 21532824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients.
    Li M; Ren L; Zhang Y; Lv J; Fang H; Zhang J; Zhao X; Han J; Huang P; Du Y; Zhang Q; Yang J; Zhang Y; Gao F
    Clin Neurol Neurosurg; 2018 Sep; 172():69-73. PubMed ID: 29986198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunostick ELISA for rapid and easy diagnosis of myasthenia gravis.
    Trakas N; Tzartos SJ
    J Immunol Methods; 2018 Sep; 460():107-112. PubMed ID: 30056940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
    Furuta N; Ishizawa K; Shibata M; Tsukagoshi S; Nagamine S; Makioka K; Fujita Y; Ikeda M; Yoshimura S; Motomura M; Okamoto K; Ikeda Y
    Intern Med; 2015; 54(19):2497-501. PubMed ID: 26424311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.
    Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
    Muscle Nerve; 2018 Dec; 58(6):796-800. PubMed ID: 30020542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.
    Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1246-52. PubMed ID: 4087000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.
    Heilbronn E; Lefvert AK; Stålberg E
    Muscle Nerve; 1978; 1(5):427-31. PubMed ID: 263985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muscle-Specific Kinase Autoimmune Myasthenia Gravis: Report of a Pediatric Case and Literature Review.
    Ben Younes T; Benrhouma H; Klaa H; Ben Aoun R; Rouissi A; Ben Ahmed M; Kraoua I; Ben Youssef-Turki I
    Neuropediatrics; 2019 Apr; 50(2):116-121. PubMed ID: 30577044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased serum IL-27 concentrations and IL-27-producing cells in MG patients with positive AChR-Ab.
    Yi M; Zhang LJ; Liu XJ; Wang N; Huang CN; Liu MQ; Chang SH; Liu WD; Yang L
    J Clin Neurosci; 2021 Apr; 86():289-293. PubMed ID: 33478780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of antibodies in myasthenia gravis.
    De Baets M; Stassen MH
    J Neurol Sci; 2002 Oct; 202(1-2):5-11. PubMed ID: 12220686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

  • 57. Myasthenia gravis.
    Nat Rev Dis Primers; 2019 May; 5(1):31. PubMed ID: 31048687
    [No Abstract]   [Full Text] [Related]  

  • 58. Subunit specificity of the acetylcholine receptor antibodies in double seropositive myasthenia gravis.
    Zouvelou V; Michail M; Belimezi M; Zisimopoulou P
    Muscle Nerve; 2021 Apr; 63(4):E36-E37. PubMed ID: 33471417
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-MuSK positivity on plasmapheresis liquid in a double seronegative myasthenia gravis patient.
    Renard D; Candon S; Jacob M; Trusson R; Reboul P
    Acta Neurol Belg; 2018 Mar; 118(1):119-120. PubMed ID: 28608313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.